This is quite different from other histological ovarian cancers such as high-grade serous ovarian carcinomas, in which an ARID1A mutation is relatively rare while p53 mutations are very frequent as essential drivers [3,11,12,31,32,33]. This evidence concerns the gene TP53 and ovarian cancer.